# Safety and Efficacy of Adefovir Dipivoxil in Children and Adolescents With Chronic Hepatitis B

> **NCT00095121** · PHASE3 · COMPLETED · sponsor: **Gilead Sciences** · enrollment: 173 (actual)

## Conditions studied

- Chronic Hepatitis B

## Interventions

- **DRUG:** Placebo (PLB)
- **DRUG:** Adefovir Dipivoxil (ADV)
- **DRUG:** Lamivudine

## Key facts

- **NCT ID:** NCT00095121
- **Lead sponsor:** Gilead Sciences
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-06
- **Primary completion:** 2006-05
- **Final completion:** 2010-04
- **Target enrollment:** 173 (ACTUAL)
- **Last updated:** 2012-05-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00095121

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00095121, "Safety and Efficacy of Adefovir Dipivoxil in Children and Adolescents With Chronic Hepatitis B". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT00095121. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*